Table 3.
Association between tolerance to chemotherapy and clinicopathological factors in patients with GI cancer and an mGPS of 1 or 2.
| Variable | n | Chemotherapeutic treatment | p | |||
|---|---|---|---|---|---|---|
| Success (n = 12) | Failure (n = 17) | |||||
| Gender | Male | 22 | 8 | 14 | 0.77 | # |
| Female | 7 | 4 | 3 | |||
| Age | <72 (median)* | 15 | 4 | 11 | 0.1 | # |
| ≧72 | 14 | 8 | 6 | |||
| Type of GI cancer | Gastrointestinal | 19 | 8 | 11 | 0.91 | # |
| Hepatobiliary and pancreatic | 10 | 4 | 6 | |||
| UICC stage classification | Stage II/III | 8 | 5 | 3 | 0.16 | # |
| Stage IV | 21 | 7 | 14 | |||
| FO-enriched nutrition | (+) | 12 | 8 | 4 | 0.05 | # |
| (−) | 17 | 5 | 12 | |||
*The median age at treatment was 72 years.
#Chi-square test.